RxDoctor Payments Data

Mathew Alexander, MD

Neurological Surgery · Corpus Christi, TXNPI 1174505887

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $387,363 of the $389,592 with a category attached, or 99.4%. Alphatec Spine, Inc accounts for 99.4% of it on its own, with 19 other manufacturers making up the rest. Among neurological surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$389,592in general payments, 2019–2025

Across 135 payments — averaging $2885.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$387K
  • Radius Health, Inc.$449
  • Boston Scientific$437
  • Si-bone, Inc.$349
  • DJO, LLC$159
  • Baxter Healthcare$104
  • plus $652 from 14 others

What the payments were for

  • Royalty or licence$387,36399%
  • Food & beverage$2,0781%
  • Education$1520%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$389,592 in reported general payments places this provider in the 95th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas

Medicare billing

Part B allowed, 2024
$257,444
Medicare patients
251
Services billed
895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide154$453,229
Nurtec OdtRimegepant Sulfate18$30,122
MounjaroTirzepatide13$13,240
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen344$12,135
Methocarbamol403$7,684
Diclofenac Potassium168$5,400
Gabapentin334$5,249
Morphine Sulfate ErMorphine Sulfate73$2,426
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav164$1,954
Pregabalin106$1,833
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine17$1,764
Lidocaine13$1,598
Duloxetine Hcl128$1,545
Diclofenac Sodium79$1,395
Vancomycin Hcl12$1,036

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$449$453,229154 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 582 neurological surgery providers in Texas.

Other neurological surgery in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →